Published in Clin J Am Soc Nephrol on May 27, 2010
Effect of Phosphorus Additives on the Metabolome in Healthy Adults | NCT03841786
The amazing osteocyte. J Bone Miner Res (2011) 5.32
Fibroblast growth factor 23 and risk of incident stroke in community-living adults. Stroke (2015) 2.06
Secreted klotho and chronic kidney disease. Adv Exp Med Biol (2012) 1.13
Dietary phosphate restriction suppresses phosphaturia but does not prevent FGF23 elevation in a mouse model of chronic kidney disease. Kidney Int (2013) 1.13
The use of targeted biomarkers for chronic kidney disease. Adv Chronic Kidney Dis (2010) 1.05
High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial. Am J Clin Nutr (2012) 1.03
Regulation of serum phosphate. J Physiol (2014) 1.03
The role of FGF23 in CKD--with or without Klotho. Nat Rev Nephrol (2012) 1.02
Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease patients. PLoS One (2014) 0.94
The effect of vitamin D status on risk factors for cardiovascular disease. Nat Rev Nephrol (2013) 0.92
Diseases of the parathyroid gland in chronic kidney disease. Clin Exp Nephrol (2011) 0.92
Sodium- and phosphorus-based food additives: persistent but surmountable hurdles in the management of nutrition in chronic kidney disease. Adv Chronic Kidney Dis (2013) 0.90
Effect of niacin on FGF23 concentration in chronic kidney disease. Am J Nephrol (2014) 0.85
Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease. J Vet Emerg Crit Care (San Antonio) (2013) 0.83
Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients. BMC Nephrol (2012) 0.79
Fibroblast growth factor 23 and acute kidney injury. Pediatr Nephrol (2014) 0.77
Phosphate Toxicity in CKD: The Killer among Us. Clin J Am Soc Nephrol (2016) 0.77
Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD. J Am Soc Nephrol (2014) 0.77
Connecting the dots on fibroblast growth factor 23 and left ventricular hypertrophy. Nephrol Dial Transplant (2016) 0.76
Propensity score matching and persistence correction to reduce bias in comparative effectiveness: the effect of cinacalcet use on all-cause mortality. Pharmacoepidemiol Drug Saf (2015) 0.75
Chronic Kidney Disease-Mineral Bone Disorder in Korean Patients: a Report from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD). J Korean Med Sci (2017) 0.75
The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney Disease. Rambam Maimonides Med J (2015) 0.75
Fibroblast Growth Factor and Mineral Metabolism Parameters among Prevalent Kidney Transplant Patients. Int J Nephrol (2012) 0.75
Effect of Calcitriol on FGF23 Level in Healthy Adults and its Dependence on Phosphate Level. In Vivo (2017) 0.75
Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease. Kidney Dis (Basel) (2016) 0.75
Phosphate Additive Avoidance in Chronic Kidney Disease. Diabetes Spectr (2017) 0.75
Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation (2009) 4.87
Low socioeconomic status associates with higher serum phosphate irrespective of race. J Am Soc Nephrol (2010) 1.46